Clinical research on radiofrequency ablation combined with splenectomy in 53 patients with small hepatocellular carcinoma associated with hypersplenism
10.3760/cma.j.issn.1007-8118.2015.02.009
- VernacularTitle:射频消融联合脾切除治疗小肝癌伴脾功能亢进53例临床研究
- Author:
Xiaoyong WU
;
Yanzhong ZHANG
;
Yu ZHANG
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Splenectomy;
Radiofrequency ablation;
Splenic function
- From:
Chinese Journal of Hepatobiliary Surgery
2015;21(2):109-112
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy of radiofrequency ablation (RFA) combined with splenectomy in patients with small hepatocellular carcinoma (sHCC) associated with hypersplenism.Metheds The data of 100 patients with sHCC associated with hypersplenism who received RFA or hepatectomy combined with splenectomy were analyzed retrospectively.The patients were divided into the observation group and the control group based on the intraoperative approach.Fifty-three patients who received RFA and splenectomy were in the observation group,and the remaining 47 patients who received hepatectomy and splenectomy were in the control group.Multiple intraoperative and postoperative factors were compared between the two groups.Results There were significant differences between the two groups in warm ischemia time,operation time,intraoperative blood loss,hospital stay,and amount of blood transfusion (P ＜ 0.05).The postoperative complication rate of the observation group (7.6％,4/53) was significantly lower than the control group (44.7 ％,21/47) (P ＜ 0.05).There were no significant differences in 1-,3-,and 5-year survival (respectively,100.0％,75.5％,and 67.9％ vs 97.9％,76.6％,and 68.1％) and in disease free survival (96.2％,57.5％,and 41.7％ vs 93.5％,58.3％,and 43.8％ respectively) between the two groups (P ＞ 0.05).Conclusion RFA combined with splenectomy can be considered as an alternative treatment for patients with sHCC associated with hypersplenism.
